[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Italy Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026

October 2022 | 37 pages | ID: I70BA258340CEN
MarketLine

US$ 350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Italy Biotechnology Market @Summary, Competitive Analysis and Forecast, 2017-2026

SUMMARY

Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS
  • The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
  • The Italian biotechnology market had total revenues of $28.1 billion in 2021, representing a compound annual growth rate (CAGR) of 24.1% between 2016 and 2021.
  • The medical/healthcare segment generated the most revenue in 2021, with total revenues of $11.7 billion, equivalent to 41.7% of the market's overall value.
  • Italy has sought to establish itself as a major competitor in the European biotechnology market. This is evidenced by the fact that it currently has the largest biotech market in Europe, accounting for 17.8% of the regional market value in 2021.
SCOPE
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts
REASONS TO BUY
  • What was the size of the Italy biotechnology market by value in 2021?
  • What will be the size of the Italy biotechnology market in 2026?
  • What factors are affecting the strength of competition in the Italy biotechnology market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Italy's biotechnology market?
1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Do leading players have any notable weaknesses?
7.4. What has been the most significant M&A activity this year?

8 COMPANY PROFILES

8.1. A Menarini Industrie Farmaceutiche Riunite Srl
8.2. Recordati S.p.A.
8.3. AGC Biologics SpA
8.4. Zambon Co SpA

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

LIST OF TABLES

Table 1: Italy biotechnology industry value: $ billion, 2016–21
Table 2: Italy biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Italy biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Italy biotechnology industry geography segmentation: $ billion, 2021
Table 5: Italy biotechnology industry value forecast: $ billion, 2021–26
Table 6: A Menarini Industrie Farmaceutiche Riunite Srl: key facts
Table 7: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees
Table 8: Recordati S.p.A.: key facts
Table 9: Recordati S.p.A.: Annual Financial Ratios
Table 10: Recordati S.p.A.: Key Employees
Table 11: AGC Biologics SpA: key facts
Table 12: AGC Biologics SpA: Key Employees
Table 13: Zambon Co SpA: key facts
Table 14: Zambon Co SpA: Key Employees
Table 15: Italy size of population (million), 2017–21
Table 16: Italy gdp (constant 2005 prices, $ billion), 2017–21
Table 17: Italy gdp (current prices, $ billion), 2017–21
Table 18: Italy inflation, 2017–21
Table 19: Italy consumer price index (absolute), 2017–21
Table 20: Italy exchange rate, 2017–21

LIST OF FIGURES

Figure 1: Italy biotechnology industry value: $ billion, 2016–21
Figure 2: Italy biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Italy biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Italy, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2021


More Publications